The Consequences of ‘Brexit’ for Drug Discovery and Development, and the Regulatory Implications

Expert Opinion on Drug Discovery - United Kingdom
doi 10.1080/17460441.2018.1463215
Full Text
Abstract

Available in full text

Categories
Drug Discovery
Date
Authors
Publisher

Informa UK Limited

Related search

Regulatory Consequences of “Brexit” for the Development of Medicinal Products

Clinical Pharmacology and Therapeutics
Pharmacology
2017English

The Implications of Model-Informed Drug Discovery and Development for Tuberculosis

Drug Discovery Today
Drug DiscoveryPharmacology
2017English

Brexit and the Law of Unintended Consequences

Survival
SociologyInternational RelationsPolitical Science
2016English

The Implications and Impact of Brexit

Pravni zapisi
2019English

Drug Discovery and Development: The Final Frontier

Prescriber
Pharmacology
2020English

The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug Targets

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

The Trade Law Consequences of “Brexit”

European Journal of Risk Regulation
Safety ResearchLaw
2016English

The Use of Minipig in Drug Discovery and Development

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
2015English

Brexit and EU Common Agricultural Policy: The Possible Consequences for Lithuania

Economics and Sociology
ManagementFinanceBusinessEconomicsSocial SciencesSociologyPolitical ScienceAccountingEconometrics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy